Novel drugs, drug sequences and combinations have improved the outcome of prostate
cancer in recent years. The latest approvals include abiraterone acetate, enzalutamide and …

Prostate specific membrane antigen (PSMA) has become a major focus point in the research
and development of prostate cancer (PCa) imaging and therapeutic strategies using …

Currently, Nuclear Medicine has a clearly defined role in clinical practice due to its
usefulness in many medical disciplines. It provides relevant diagnostic and therapeutic …

Purpose Targeting the prostate-specific membrane antigen (PSMA) using lutetium-177-
labeled PSMA-specific tracers has become a very promising novel therapy option for …

Although management of advanced prostate cancer is evolving, a lot of work remains to be
done for patients who have exhausted all options. Molecular targeting of prostate specific …

Macrophages in the cancer microenvironments may play a regulatory role in the progression
and metastasis of prostate cancer cells. However, the crosstalk between macrophages and …

Simple Summary Regucalcin plays a multifunctional role in the regulation of cell function
and expresses a repressive effect in the growth of normal cells. Of note, there is increasing …

Cellular senescence is a therapy endpoint in melanoma, and the senescence-associated
secretory phenotype (SASP) can affect tumor growth and microenvironment, influencing …

Radioligand therapy (RLT) is gaining traction as a safe and effective targeted approach for
the treatment of many cancer types, reflected by a substantial and growing commercial …

Targeted α-particle–emitting radionuclides have great potential for the treatment of a broad
range of cancers at different stages of progression. A platform that accurately measures …